Aciclovir monophosphate

Drug Profile

Aciclovir monophosphate

Alternative Names: ACVMP; Acyclovir monophosphate

Latest Information Update: 20 Feb 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Developer Nonindustrial source; Triangle Pharmaceuticals
  • Class Antivirals
  • Mechanism of Action DNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Herpes simplex virus infections

Most Recent Events

  • 30 May 2001 Suspended-Preclinical for Herpes simplex virus infections in USA (Topical)
  • 29 Jun 1998 A preclinical study has been added to the pharmacodynamics section
  • 26 May 1998 Triangle Pharmaceuticals plans to suspend development after completion of preclinical and formulation studies in order to concentrate on other projects
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top